IN8bio
INAB
INAB
13 hedge funds and large institutions have $7.8M invested in IN8bio in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $12.2M → $7.8M (-$4.39M)
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$307K | |
| 2 | +$126K | |
| 3 | +$92.3K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$44K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.2K |
Top Sellers
| 1 | -$434K | |
| 2 | -$292K | |
| 3 | -$175K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$8.03K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.86K |